// App-Quantinova.ai

: Incidence of Post-Hematopoietic Stem Cell Transplantation (HSCT) Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) without Hyperbilirubinemia at Diagnosis and Efficacy of Defibrotide in an Expanded-Access Program

Researchers

Presenter

  • Selim Corbacioglu

Principal Investigators

  • Nancy A. Kernan

  • Antonio Pagliuca

  • Robert Ryan

  • William Tappe

  • Paul Richardson

Medical Centers

  • Internal Medicine III, Department of Hematology, Oncology and Stem Cell Transplantation, University Hospital Regensburg, Regensburg, Germany

  • Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, NY

  • Kings College London, London, United Kingdom

  • Jazz Pharmaceuticals, Palo Alto, CA

  • Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA

Locations

  • Germany

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Hepatic veno-occlusive disease with immunodeficiency

  • Hyperbilirubinemia

Biomarkers

  • N/A

Drug/Treatment

  • Defibrotide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved